How a global shortage of contrast dye is affecting CT scans, tests at Michigan hospitals
By Kristen Jordan Shamus
A shortage of contrast dye used for CT scans, gastrointestinal imaging, angiograms and cardiac catheterizations is expected to cause delays across the country and around the world in need of the procedures. The shortage of iodine-based contrast dye was sparked by ongoing COVID-19 lockdowns in Shanghai, China, which have forded GE Healthcare’s pharmaceutical manufacturing plant to temporarily close. Dr. Daniel Myers, a vice chairman of radiology at Henry Ford Health System and clinical professor of radiology at Wayne State University’s School of Medicine, said the hospital system’s supply has been interrupted. “We have had meetings with folks at Bracco and discussed it…We’ve had assurances from them that there won’t be issues for customers such as Henry Ford Health, who obtain a high percentage of our contrast from them…” Myers said. Myers said he’s like to think the impact in Michigan will be minimal, and it’s important for people to continue scheduling testing as their doctors recommend. “I don’t want people to think they shouldn’t go see their doctors because they won’t get an adequate test. People need to get their health care.”